LI
CRL icon

LMCG Investments’s Charles River Laboratories CRL Stock Holding History

LMCG Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,021
Closed -$417K – 235
2024
Q2 		$417K Sell
2,021
-4
-0.2% -$906 0.02% 256
2024
Q1 		$549K Sell
2,025
-736
-27% -$176K 0.03% 250
2023
Q4 		$653K Hold
2,761
– – 0.04% 248
2023
Q3 		$541K Buy
2,761
+53
+2% +$10.9K 0.04% 254
2023
Q2 		$569K Hold
2,708
– – 0.04% 251
2023
Q1 		$547K Buy
2,708
+57
+2% +$12.9K 0.04% 248
2022
Q4 		$578K Buy
2,651
+5
+0.2% +$1.09K 0.04% 248
2022
Q3 		$521K Buy
+2,646
New +$571K 0.04% 266
2015
Q3 		$29.1M Buy
458,584
+7,343
+2% +$527K 0.62% 22
2015
Q2 		$31.7M Sell
451,241
-120,689
-21% -$8.93M 0.68% 21
2015
Q1 		$45.3M Sell
571,930
-110,734
-16% -$8.17M 0.95% 4
2014
Q4 		$43.4M Sell
682,664
-66,672
-9% -$4.18M 0.95% 5
2014
Q3 		$44.8M Buy
749,336
+4,028
+0.5% +$230K 1% 3
2014
Q2 		$39.9M Buy
745,308
+54,293
+8% +$2.98M 0.86% 7
2014
Q1 		$41.7M Sell
691,015
-31,030
-4% -$1.81M 0.92% 7
2013
Q4 		$38.3M Buy
722,045
+34,369
+5% +$1.73M 0.81% 10
2013
Q3 		$31.8M Buy
687,676
+81,988
+14% +$3.76M 0.77% 17
2013
Q2 		$24.9M Buy
+605,688
New +$26M 0.65% 33

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

LMCG Investments's CRL Position: Q3 2024 in Review

LMCG Investments sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 2,021 shares — an estimated $417K sold.

LMCG Investments first reported a position in CRL in Q2 2013 and held it in 18 quarters. The position peaked at $45.3M in Q1 2015. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • LMCG Investments reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • LMCG Investments sold 2,021 Charles River Laboratories shares in Q3 2024, an estimated $417K.
  • LMCG Investments first reported a position in Charles River Laboratories in Q2 2013 and held it in 18 quarters.
  • LMCG Investments's Charles River Laboratories position peaked at $45.3M in Q1 2015.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on LMCG Investments's 13F filing for Q3 2024, filed 29 Oct 2024.